October 29, Sincerely, Robert A. Quin Vice President of Finance & CFO. Enclosure

Transcription

1 October 29, 2013 Pursuant to Section 414(A) of the Master Trust Indenture between The Methodist Medical Center of Illinois and The Bank of New York Mellon Trust Company, N.A., dated as of May 1, 2011, as amended by the First Supplemental Master Trustee Indenture, dated as of May 1, 2011, the undersigned hereby submits unaudited financial statements, dated September 30, 2013, for The Methodist Medical Center of Illinois. I certify that the aforementioned financial statements were taken from the records and present fairly the financial position, the results of its operations and changes in financial position of The Methodist Medical Center of Illinois. Sincerely, Robert A. Quin Vice President of Finance & CFO Enclosure 221 Northeast Glen Oak Avenue Peoria, Illinois Phone: MyMethodist.net

2 METHODIST MEDICAL CENTER OF ILLINOIS QUARTERLY FINANCIAL STATEMENTS FOR THE QUARTER ENDED SEPTEMBER 30, 2013

3 Balance Sheet (in thousands) September 30, December 31, ASSETS (unaudited) (audited) Current Assets Cash and Cash Equivalents $ 38,279 $ 27,285 Short-term investments Patient accounts receiveable, less estimated uncollectibles 41,430 55,875 Other Receivables 4,459 4,695 Prepaid Expenses 4,369 2,938 Inventories 3,693 3,807 Due From Affiliates 4,891 4,482 Total Current Assets 97,531 99,495 Assets Limited as to Use, Noncurrent Internally designated 3,930 3,701 Total Assets Limited as to Use, Noncurrent 3,930 3,701 Property, Plant and Equipment, Net 161, ,669 Other Assets Investment Securities 161, ,513 Other Long-term Investments 6,643 6,737 Investments in Joint Ventures and Other Investments 31,866 30,745 Contributions Receivable 5,787 5,787 Deferred Financing Costs and Other Assets 1,220 1,318 Total Other Assets 206, ,101 Total Assets $ 470,142 $ 454,965 LIABILITIES AND NET ASSETS Current Liabilities Current Installments of Long Term Debt $ 5,170 $ 5,365 Accounts Payable 15,571 23,494 Accrued Expenses: Accrued Payroll 11,390 11,275 Accured Interest Due to Affiliates Estimated Net Settlements Due to Third-Party Payors 35,186 31,369 Other Current Liabilities 7,711 7,173 Total Current Liabilities 75,351 79,594 Long Term Debt, net 99,010 99,010 Other Long Term Liabilities 106, ,975 Total Liabilities 281, ,580 NET ASSETS Unrestricted 173, ,268 Temporarily Restricted 11,023 10,134 Permanently Restricted 4,031 3,984 Total Net Assets 188, ,385 Total Liabilities and Net Assets $ 470,142 $ 454,965

4 Statement of Operations (Unaudited) (in thousands) Three Months Ended Nine Months Ended September 30, September 30, Unrestricted Revenue $ 83,298 $ 84,950 Net Patient Revenue $ 249,342 $ 253,772 5,921 6,114 Other Operating Revenue 18,566 18,114 89,219 91,064 Total unrestricted revenue 267, ,886 Operating Expense 27,131 27,887 Salaries 80,814 81,492 11,440 11,094 Physician Compensation and Benefits 33,994 34,189 6,305 7,580 Employee Benefits 19,184 23,677 12,247 12,486 Supplies Expense 37,733 38,162 21,865 21,758 Other Expenses 66,225 64,568 5,344 5,446 Depreciation & Amortization 16,424 16, Interest 1,722 1,912 84,883 86,893 Total Operating Expense 256, ,700 4,336 4,171 Operating Income 11,811 11,187 Nonoperating Gains (Losses) 4,850 5,082 Investment Income 8,992 10, ,328 Other Non-Operating Income (loss) (504) 2,582 5,296 6,410 Total nonoperating gains (losses), net 8,488 13,549 $ 9,632 $ 10,581 Revenue Over Expense $ 20,299 $ 24,735

5 Statement of Changes in Net Assets (Unaudited) (In thousands) Three Months Ended Nine Months Ended September 30, September 30, Unrestricted Net Assets $ 9,632 $ 10,581 Excess revenue over expenses $ 20,299 $ 24,735 (705) Transfers to affiliates, net (1,788) Net assets released from restrictions - used for capital expenditures Change in beneficial interest in net assets of affiliate 978 1,443 Equity Contribution from affliates - 9,710 11,158 Increase (Decrease) in unrestricted net assets 19,635 26,360 Temporarily Restricted Net Assets Contributions (100) (90) Net assets released from restriction - operations (245) (265) Change in beneficial interest in net assets of affiliate Increase (Decrease) in temporarily restricted net assets Permanently Restricted Net Assets Change in beneficial interest in net assets of affiliate Increase (Decrease) in permanently restricted net assets ,189 11,512 Increase (Decrease) in Net Assets 20,571 27, , ,840 Net Assets, Beginning of Period 168, ,114 $ 188,956 $ 146,352 Net Assets, End of Period $ 188,956 $ 146,352

6 Statements of Cash Flows (Unaudited) (In thousands) Three Months Ended Nine Months Ended September 30, September 30, Operating Activities $ 10,189 $ 11,512 Increase (decrease) in net assets $ 20,571 $ 27,238 Items not requiring (providing) operating cash: (4,850) (5,082) Net (gains) losses on investments (8,992) (10,967) (253) (1,142) Net (gains) losses on swaps 1,081 (2,011) (86) - Restricted contributions, investment income and government grants received (255) - 5,361 5,463 Depreciation and amortization 16,476 16, (Gain) Loss on sale of assets (3) 18 (1,200) (360) Change in beneficial interest in net assets of affiliates (1,880) (892) Changes in working capital: 113 (3,512) Receivables 14,682 (1,243) 1,492 1,342 Inventories, prepaid expenses, other assets (1,271) 2,064 4,493 5,205 Accounts payable, accrued liabilities and other liabilities 158 (12,180) (4,540) (2,687) Due to affiliates (987) 2,026 4,172 4,544 Due to third party payers 3,817 3,414 11,959 15,283 Net cash provided by operating activities 37,537 24,217 Investing Activities (5,238) (7,108) Capital expenditures (15,385) (12,235) (158) 845 (Increase) decrease in assets limited as to use, net (229) 1,333 (976) (9,980) (Increase) decrease in other long-term investments (12,649) (12,415) (Investments in) distributions from joint ventures, net (5,388) (15,806) Net cash (used in) provided by investing activities (27,505) (22,364) Financing Activities - - Payments on bonds and other long-term debt (195) (512) Proceeds from restricted contrib., invest. inc & govt grants 1, Net cash (used in) provided by financing activities ,126 (162) Increase (Decrease) in Cash and Cash Equivalents, for the period 10,994 2,234 31,153 19,816 Cash and Cash Equivalents, beginning of period 27,285 17,420 $ 38,279 $ 19,654 Cash and Cash Equivalents, end of period $ 38,279 $ 19,654